WINNIPEG, MANITOBA -- (MARKET WIRE) -- September 26, 2006 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting at BioContact Quebec 2006 in Quebec City, October 4-6.
